137 related articles for article (PubMed ID: 17121373)
1. [Alzheimer's disease and oxidative stress].
Yu D; Wei C; Bao Y; An L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Oct; 23(5):1142-4, 1148. PubMed ID: 17121373
[TBL] [Abstract][Full Text] [Related]
2. [Alzheimer's disease: advance in researches on Beta-amyloid protein].
Liu J; Bao Y; An L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):371-4. PubMed ID: 12856622
[TBL] [Abstract][Full Text] [Related]
3. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
Crouch PJ; White AR; Bush AI
FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
[TBL] [Abstract][Full Text] [Related]
4. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system.
de Vrij FM; Fischer DF; van Leeuwen FW; Hol EM
Prog Neurobiol; 2004 Dec; 74(5):249-70. PubMed ID: 15582222
[TBL] [Abstract][Full Text] [Related]
5. Current and future therapy in Alzheimer's disease.
van Marum RJ
Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress signalling in Alzheimer's disease.
Zhu X; Raina AK; Lee HG; Casadesus G; Smith MA; Perry G
Brain Res; 2004 Mar; 1000(1-2):32-9. PubMed ID: 15053949
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
Crouch PJ; Harding SM; White AR; Camakaris J; Bush AI; Masters CL
Int J Biochem Cell Biol; 2008; 40(2):181-98. PubMed ID: 17804276
[TBL] [Abstract][Full Text] [Related]
8. beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Butterfield DA
Chem Res Toxicol; 1997 May; 10(5):495-506. PubMed ID: 9168246
[No Abstract] [Full Text] [Related]
9. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease.
Perez-Gracia E; Blanco R; Carmona M; Carro E; Ferrer I
Acta Neuropathol; 2009 Oct; 118(4):497-504. PubMed ID: 19597827
[TBL] [Abstract][Full Text] [Related]
11. The role of intracellular amyloid beta in Alzheimer's disease.
Li M; Chen L; Lee DH; Yu LC; Zhang Y
Prog Neurobiol; 2007 Oct; 83(3):131-9. PubMed ID: 17889422
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
13. Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease.
Bica L; Crouch PJ; Cappai R; White AR
Mol Biosyst; 2009 Feb; 5(2):134-42. PubMed ID: 19156258
[TBL] [Abstract][Full Text] [Related]
14. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.
Atwood CS; Huang X; Moir RD; Tanzi RE; Bush AI
Met Ions Biol Syst; 1999; 36():309-64. PubMed ID: 10093929
[No Abstract] [Full Text] [Related]
15. Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
Castellani RJ; Zhu X; Lee HG; Moreira PI; Perry G; Smith MA
Expert Rev Neurother; 2007 May; 7(5):473-85. PubMed ID: 17492899
[TBL] [Abstract][Full Text] [Related]
16. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows.
Praticò D
Ann N Y Acad Sci; 2008 Dec; 1147():70-8. PubMed ID: 19076432
[TBL] [Abstract][Full Text] [Related]
17. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
Crouch PJ; Barnham KJ; Bush AI; White AR
Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
[TBL] [Abstract][Full Text] [Related]
19. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
[TBL] [Abstract][Full Text] [Related]
20. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.
Zetterberg H
Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
